Cargando…

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?

Detalles Bibliográficos
Autores principales: Bobkova, Irina, Kamyshova, Elena, Rudenko, Tatiana, Stavrovskaya, Ekaterina, Moiseev, Sergey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251351/
https://www.ncbi.nlm.nih.gov/pubmed/32480248
http://dx.doi.org/10.1016/j.mehy.2020.109888
_version_ 1783538947367895040
author Bobkova, Irina
Kamyshova, Elena
Rudenko, Tatiana
Stavrovskaya, Ekaterina
Moiseev, Sergey
author_facet Bobkova, Irina
Kamyshova, Elena
Rudenko, Tatiana
Stavrovskaya, Ekaterina
Moiseev, Sergey
author_sort Bobkova, Irina
collection PubMed
description
format Online
Article
Text
id pubmed-7251351
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72513512020-05-27 Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19? Bobkova, Irina Kamyshova, Elena Rudenko, Tatiana Stavrovskaya, Ekaterina Moiseev, Sergey Med Hypotheses Article Elsevier Ltd. 2020-10 2020-05-27 /pmc/articles/PMC7251351/ /pubmed/32480248 http://dx.doi.org/10.1016/j.mehy.2020.109888 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bobkova, Irina
Kamyshova, Elena
Rudenko, Tatiana
Stavrovskaya, Ekaterina
Moiseev, Sergey
Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
title Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
title_full Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
title_fullStr Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
title_full_unstemmed Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
title_short Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
title_sort is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with covid-19?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251351/
https://www.ncbi.nlm.nih.gov/pubmed/32480248
http://dx.doi.org/10.1016/j.mehy.2020.109888
work_keys_str_mv AT bobkovairina isthereenoughevidencetodiscontinuethereninangiotensinsysteminhibitorsinpatientswithcovid19
AT kamyshovaelena isthereenoughevidencetodiscontinuethereninangiotensinsysteminhibitorsinpatientswithcovid19
AT rudenkotatiana isthereenoughevidencetodiscontinuethereninangiotensinsysteminhibitorsinpatientswithcovid19
AT stavrovskayaekaterina isthereenoughevidencetodiscontinuethereninangiotensinsysteminhibitorsinpatientswithcovid19
AT moiseevsergey isthereenoughevidencetodiscontinuethereninangiotensinsysteminhibitorsinpatientswithcovid19